Rbs Pharma (roger Bellon Schoum) S.p.a.

Isf S.p.a.

Piero Bellani

Gaetano Clavenna

Rinaldo Pellegrini

Mario Pinza

Roberto P Giani

Giampietro Broccali

Goffredo Bolis

Alberta Sosio

A new use of N-(4'-pyridyl)-3,3-diphenylpropyl amine, known as fenpyramin, as platelet aggregation-inhibiting medicine and antithrombotic agent as well as vasodilating and antianginous medicine is described.

Use of fenpyramin as platelet-antiaggregating, vasodilating,

New imidazopyridine derivatives are described, having the following formula: ##STR1## wherein R represents a hydrogen atom, an alkyl radical of 1 to 3 carbon atoms, a methoxy group or a halogen atom,

Imidazopyridine compounds

There is described a new class of ketohydroxyimino derivatives of cephalosporins of the formula ##STR1## wherein: R is an alkyl radical having from 2 to 4 carbon atoms, a phenyl, or a 5-membered heterocyclic radical which may be substituted, containing nitrogen, oxygen and/or sulphur;

Ketoiminocephalosporin derivatives

Growing community of inventors

Milan, Italy

Piero Bellani